Renovacor, Inc. (RCOR) Financial Statements (2024 and earlier)

Company Profile

Business Address 201 BROADWAY
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2022
MRQ
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 78,790,000687,313
Cash and cash equivalents 78,790,000687,313
Prepaid expense 1,763,00030,217
Total current assets: 80,553,000717,530
Noncurrent Assets
Property, plant and equipment 379,000 
Long-term investments and receivables  86,247,631
Long-term investments  86,247,631
Other noncurrent assets 67,000 
Total noncurrent assets: 446,00086,247,631
TOTAL ASSETS: 80,999,00086,965,161
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 4,034,000359,438
Accounts payable 1,536,000 
Accrued liabilities 2,498,000 
Other undisclosed accounts payable and accrued liabilities  359,438
Total current liabilities: 4,034,000359,438
Noncurrent Liabilities
Liabilities, other than long-term debt 11,165,000500,000
Due to related parties  500,000
Derivative instruments and hedges, liabilities 11,165,000 
Other undisclosed noncurrent liabilities 12,256,000 
Total noncurrent liabilities: 23,421,000500,000
Total liabilities: 27,455,000859,438
Equity
Equity, attributable to parent 53,544,0005,000,003
Common stock 2,000266
Additional paid in capital 72,540,0005,782,977
Accumulated other comprehensive loss  (783,240)
Accumulated deficit (18,998,000) 
Other undisclosed equity  81,105,720
Total equity: 53,544,00086,105,723
TOTAL LIABILITIES AND EQUITY: 80,999,00086,965,161

Income Statement (P&L) (USD)

9/30/2022
TTM
12/31/2021
12/31/2020
Operating expenses (18,629,000)(801,961)
Operating loss: (18,629,000)(801,961)
Loss from continuing operations before income taxes: (18,629,000)(801,961)
Income tax benefit  164,481
Loss from continuing operations: (18,629,000)(637,480)
Loss before gain (loss) on sale of properties:(18,629,000)(637,480)
Other undisclosed net income (loss) 4,528,000(143,290)
Net loss available to common stockholders, diluted: (14,101,000)(780,770)

Comprehensive Income (USD)

9/30/2022
TTM
12/31/2021
12/31/2020
Net loss: (14,101,000)(780,770)
Comprehensive loss, net of tax, attributable to parent: (14,101,000)(780,770)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: